RadNet Shares Outstanding 2010-2024 | RDNT

RadNet shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
RadNet Annual Shares Outstanding
(Millions of Shares)
2024 75
2023 65
2022 57
2021 53
2020 51
2019 50
2018 49
2017 47
2016 47
2015 45
2014 43
2013 40
2012 39
2011 39
2010 37
2009 36
RadNet Quarterly Shares Outstanding
(Millions of Shares)
2024-12-31 75
2024-09-30 75
2024-06-30 73
2024-03-31 69
2023-12-31 65
2023-09-30 69
2023-06-30 61
2023-03-31 58
2022-12-31 57
2022-09-30 58
2022-06-30 57
2022-03-31 56
2021-12-31 53
2021-09-30 54
2021-06-30 53
2021-03-31 53
2020-12-31 51
2020-09-30 52
2020-06-30 51
2020-03-31 50
2019-12-31 50
2019-09-30 50
2019-06-30 50
2019-03-31 50
2018-12-31 49
2018-09-30 49
2018-06-30 49
2018-03-31 48
2017-12-31 47
2017-09-30 48
2017-06-30 47
2017-03-31 47
2016-12-31 47
2016-09-30 46
2016-06-30 47
2016-03-31 47
2015-12-31 45
2015-09-30 45
2015-06-30 45
2015-03-31 43
2014-12-31 43
2014-09-30 44
2014-06-30 43
2014-03-31 40
2013-12-31 40
2013-09-30 39
2013-06-30 40
2013-03-31 39
2012-12-31 39
2012-09-30 40
2012-06-30 39
2012-03-31 38
2011-12-31 39
2011-09-30 38
2011-06-30 40
2011-03-31 37
2010-12-31 37
2010-09-30 37
2010-06-30 37
2010-03-31 36
2009-12-31 36
2009-09-30 36
2009-06-30 36
2009-03-31 36
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.929B $1.830B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.896B 19.61
Encompass Health (EHC) United States $11.782B 25.00
DaVita (DVA) United States $10.880B 14.44
Chemed (CHE) United States $8.507B 26.74
Option Care Health (OPCH) United States $5.291B 23.58
Elanco Animal Health (ELAN) United States $4.706B 10.42
Amedisys (AMED) United States $3.115B 20.95
LifeStance Health (LFST) United States $2.555B 0.00
Addus HomeCare (ADUS) United States $1.924B 22.01
Astrana Health (ASTH) United States $1.748B 35.02
U.S Physical Therapy (USPH) United States $1.080B 27.56
Aveanna Healthcare Holdings (AVAH) United States $0.899B 0.00
Pennant (PNTG) United States $0.890B 35.58
Atai Life Sciences (ATAI) Germany $0.300B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00